Determination of the New Ace-Inhibitor Quinapril and Its Active Metabolite Quinaprilate in Plasma and Urine by High-Performance Liquid Chromatography and Pre-Column Labelling for Fluorescent-Detection
- 1 February 1988
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography
- Vol. 11 (2) , 517-530
- https://doi.org/10.1080/01483918809349956
Abstract
A sensitive and selective method for the determination of quinapril and its active metabolite quinaprilate in human plasma and urine is described. The method is based on isolation using C18 Bond Elut cartridges, pre-column derivatization with 9-anthryldiazo-methane and purification of the reaction mixture on CBA columns followed by reversed-phase high performance liquid chromatography with fluorometric detection. Calibration curves were linear between 20 ng and 1000 ng/ml of plasma (100-2000 ng for urine) for both substances, the lower limit of detection being 5-10 ng/ml. The present assay procedure has been applied to monotoring plasma and urine concentrations in several pharmacokinetic studies in humans.This publication has 6 references indexed in Scilit:
- Direct determination of angiotensin-converting enzyme inhibitors in plasma by radioenzymatic assay.Clinical Chemistry, 1987
- Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packingsJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl typesJournal of Medicinal Chemistry, 1986
- Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urineAnalytical Biochemistry, 1985
- The Syntheses and the Reactions of 9-Anthryldiazomethane and α-NaphthyldiazomethaneBulletin of the Chemical Society of Japan, 1967